Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for kids with tough cancers: experimental drug trial opens

NCT ID NCT04928677

Summary

This early-stage study is testing whether an experimental drug called codrituzumab is safe for children and young adults with solid tumors that have returned or stopped responding to standard treatments. The trial will enroll up to 50 participants aged 1 to 21 years whose tumors produce a specific protein called GPC3. Researchers will carefully monitor side effects and how the drug moves through the body to determine appropriate doses for future studies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY EXTRA-CRANIAL SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Healthcare of Atlanta (Data Collection Only)

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Children's Hospital of Los Angeles (Data Collection Only)

    RECRUITING

    Los Angeles, California, 90027, United States

    Contact Phone: •••-•••-••••

  • Cincinnati Children's Hospital Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229, United States

    Contact Phone: •••-•••-••••

  • Dana Farber Cancer Institute (Data Collection Only)

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-••••

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.